Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $67.1 Million - $88.3 Million
-1,666,076 Reduced 99.43%
9,507 $394,000
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $11.9 Million - $13.5 Million
248,986 Added 17.45%
1,675,583 $90.9 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $28.3 Million - $33.7 Million
583,268 Added 69.16%
1,426,597 $73.2 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $53.7 Million - $59.7 Million
843,329 New
843,329 $53.9 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $74 - $43,798
570 New
570 $41,000
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $9.2 Million - $10.7 Million
-171,600 Reduced 90.54%
17,935 $1.12 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $10.8 Million - $12.7 Million
182,945 Added 2776.1%
189,535 $11.2 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $407,986 - $444,297
6,590 New
6,590 $440,000
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $51.8 Million - $58.2 Million
-872,140 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $18.3 Million - $20.7 Million
316,954 Added 57.09%
872,140 $54.1 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $8.56 Million - $9.48 Million
149,004 Added 36.68%
555,186 $33.5 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $151 Million - $176 Million
-2,746,144 Reduced 87.11%
406,182 $23.9 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $132 Million - $193 Million
2,854,960 Added 960.08%
3,152,326 $176 Million
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $11.8 Million - $13.1 Million
265,233 Added 825.42%
297,366 $13.5 Million
Q1 2019

May 08, 2019

BUY
$45.12 - $53.8 $449,034 - $535,417
9,952 Added 44.87%
32,133 $1.53 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $1.04 Million - $1.36 Million
21,430 Added 2853.53%
22,181 $1.15 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $1.24 Million - $1.4 Million
-22,516 Reduced 96.77%
751 $47,000
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $10.8 Million - $13.5 Million
-214,481 Reduced 90.21%
23,267 $1.29 Million
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $13.7 Million - $14.9 Million
227,748 Added 2277.48%
237,748 $14.6 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $552,300 - $637,400
10,000
10,000 $637,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.